Have your say and take our survey
In 2017 MSNZ officially endorsed ‘Brain Health: time matters in MS’ , an international consensus report providing recommendations on diagnosis, therapeutic strategies and improving access to treatment in MS. Since then we have used the principles to direct and provide international support for our advocacy work into improving the access to treatments and services for people […]
Brain health: time matters in MS
On Saturday 26th May Professor Helmut Butzkueven was invited to speak at the annual MS Auckland Research Day. Professor Butzkueven was in the country to speak on behalf of Multiple Sclerosis New Zealand at three advocacy meetings regarding the importance of preserving brain health and particularly the need to access disease modifying drugs (DMTs) earlier […]
Advocating For Increased Access to MS Treatments
On Monday 28th May Multiple Sclerosis New Zealand (MSNZ) with Professor Helmut Butzkueven, of Monash University in Melbourne, met with members of PHARMAC staff to discuss our continued concerns with the very restrictive access criteria for MS disease modifying treatments (DMTs). Following this meeting we made a further official submission to PHARMAC. This submission followed […]